The medically-certified multi-parameter wearable designed for continuous monitoring of vital signs enhances the Medtronic portfolio of patient monitoring solutions.

经过医学认证的多参数可穿戴设备，用于持续监测生命体征，增强了美敦力的患者监测解决方案组合。

Medtronic, a global leader in healthcare technology, has announced a new strategic partnership with Corsano Health B.V., a pioneering MedTech company specializing in advanced real-time remote patient monitoring solutions. Medtronic will exclusively distribute Corsano Health’s cutting-edge solution in Western Europe for hospital and hospital-at-home use, enhancing remote monitoring capabilities and.

全球医疗技术领导者美敦力宣布与先锋医疗技术公司Corsano Health B.V.达成新的战略合作伙伴关系，该公司专注于先进的实时远程患者监测解决方案。美敦力将独家在西欧分销Corsano Health的尖端解决方案，用于医院和家庭医院场景，提升远程监测能力。

transforming patient care across healthcare settings. Additional terms of the agreement were not disclosed.

在各种医疗环境中转变患者护理。协议的其他条款未被披露。

The multi-parameter wearable solution by Corsano Health is a state-of-the-art, medically-certified multi-sensor wearable designed for continuous monitoring of vital signs.1 With features like heart rate, breathing rate, SpO2, cuffless non-invasive blood pressure monitoring, and ECG, the Corsano™ solution provides clinicians with seamless, real-time data to non-invasively monitor patients anytime, anywhere.1.

Corsano Health的多参数可穿戴解决方案是一种最先进的、经过医学认证的多传感器可穿戴设备，旨在持续监测生命体征。1 通过心率、呼吸频率、血氧饱和度、无袖带非侵入式血压监测和心电图等功能，Corsano™ 解决方案为临床医生提供了无缝的实时数据，可以在任何时间、任何地点非侵入性地监测患者。1

By enabling data-driven decision-making, this technology supports the principles of value-based healthcare, ensuring that patients are uninterruptedly monitored throughout the healthcare continuum. Many studies show that continuous monitoring not only helps reduce unplanned critical care readmissions and detect complications but also empowers clinicians with actionable insights to prioritize care and intervene earlier ultimately improving patient outcomes†2-8.

通过启用数据驱动的决策，这项技术支持基于价值的医疗保健原则，确保患者在整个医疗过程中得到不间断的监测。许多研究表明，持续监测不仅有助于减少计划外重症护理的再入院和发现并发症，还为临床医生提供了可操作的见解，以优先处理护理并及早干预，最终改善患者的治疗效果†2-8。

This aligns with the Medtronic Mission to deliver innovative solutions that enhance healthcare delivery, optimize resource utilization, and improve patient management across the continuum of care..

这与美敦力公司通过提供创新解决方案，改善医疗服务、优化资源利用并在整个医疗过程中提升患者管理水平的使命相一致。

“The Corsano™ multi-parameter wearable will enhance our portfolio of patient monitoring solutions and help to protect more patients in more places. This innovation empowers our healthcare professionals with real-time tracking and predictive analytics designed to inform clinician decision- making.1 With the Corsano™ multi-parameter wearable solution clinicians instantly connect to real- time patient data through a powerful, flexible monitoring platform.

“Corsano™多参数可穿戴设备将增强我们的患者监测解决方案组合，并帮助在更多地方保护更多患者。这一创新使我们的医疗专业人员能够通过实时跟踪和预测分析来辅助临床决策。通过Corsano™多参数可穿戴解决方案，临床医生可以通过一个强大而灵活的监测平台即时连接到患者的实时数据。

It is a scalable, future-ready solution for hospitals seeking to modernize care by maximizing their monitoring functionality.1 Together, we are transforming the healthcare landscape, turning aspirations into reality, and forging a future where safety and excellence go hand in hand,” said Marc De Martini, vice president, Western.

马克·德·马蒂尼，西部地区副总裁表示：“它是一个可扩展的、面向未来的解决方案，适用于那些希望通过最大化其监控功能来实现护理现代化的医院。1 我们正在共同改变医疗保健领域的面貌，将愿望变为现实，并打造一个安全与卓越并存的未来。

Europe Commercial, Acute Care and Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic.

欧洲商业、急症护理和监测业务，是美敦力医疗外科产品组合的一部分。

Corsano Health’s CEO, Peter Stas, expressed his enthusiasm for the partnership, stating, “Our mission at Corsano Health is to transform healthcare by delivering actionable insights that enhance patient outcomes—seamlessly, from hospital to home. Through this innovation, we aim to empower clinicians with advanced remote monitoring capabilities to simplify workflows and provide proactive care.

Corsano Health首席执行官彼得·斯塔斯对此次合作表示热情，并说道：“我们在Corsano Health的使命是通过提供可操作的洞察来改善患者的治疗效果，从而改变医疗保健模式——从医院到家庭无缝衔接。通过这一创新，我们旨在赋予临床医生先进的远程监控能力，简化工作流程并提供主动的护理。”

Together, we are redefining connected care models to support the evolving needs of healthcare systems, addressing workforce shortages while enabling personalized and efficient patient management at every stage of care.”.

“我们正在共同努力，重新定义互联护理模式，以支持不断发展的医疗系统需求，在解决劳动力短缺问题的同时，实现各个护理阶段的个性化和高效患者管理。”

This partnership underscores the critical role of continuous monitoring in optimizing patient pathways. The Corsano™ solution’s ability to provide unrestricted access to raw data for AI development further supports the commitment from Medtronic to integrating cutting-edge technology with world-class medical devices.

这种合作伙伴关系强调了持续监测在优化患者路径中的关键作用。Corsano™ 解决方案能够为人工智能开发提供对原始数据的无限制访问，这进一步支持了美敦力将尖端技术与世界级医疗设备相结合的承诺。

Learn more about the Corsano™ multi-parameter wearable from Medtronic .

了解有关美敦力 Corsano™ 多参数可穿戴设备的更多信息。

here

这里

.

。

About Corsano Health

关于Corsano Health

Corsano Health B.V. is a leading MedTech company that creates, manufactures, and sells advanced real-time remote patient monitoring solutions. With a CE-MDR medically certified system and FDA clearance, the Corsano™ multi-parameter wearable is setting new standards for continuous monitoring, focusing on our mission to lower healthcare costs and support clinical teams in improving outcomes and patient experiences.

Corsano Health B.V. 是一家领先的医疗技术公司，专注于创造、制造和销售先进的实时远程患者监测解决方案。凭借获得CE-MDR医学认证的系统以及FDA批准，Corsano™多参数可穿戴设备正在为持续监测树立新标准，致力于降低医疗成本，并帮助临床团队改善治疗效果和患者体验。

For more information, visit .

欲了解更多信息，请访问。

https://corsano.com/

https://corsano.com/

.

。

About Medtronic

美敦力公司简介

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更大胆的行动。我们是美敦力。美敦力公司总部位于爱尔兰戈尔韦，是全球领先的医疗技术公司，通过寻找和发现解决方案，勇敢地应对人类面临的最具挑战性的健康问题。我们的使命——减轻痛苦、恢复健康、延长生命——将遍布150多个国家的95,000多名充满热情的员工团结在一起。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们多样化的知识、无尽的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新的技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

随着我们助力以洞察力为导向的护理、以人为本的体验以及为我们的世界带来更好的结果，期待我们做出更多贡献。在我们所做的每一件事中，我们都在创造非凡。欲了解有关美敦力的更多信息，请访问。

www.Medtronic.com

www.Medtronic.com

and follow on

接着进行

LinkedIn

领英

.

。

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

任何前瞻性陈述均受风险和不确定性的影响，例如美敦力向证券交易委员会提交的定期报告中描述的那些。实际结果可能与预期结果有重大差异。

The Corsano™ multi-parameter wearable is manufactured by Corsano Health B.V and distributed by Medtronic.

Corsano™ 多参数可穿戴设备由 Corsano Health B.V 制造，美敦力公司分销。

The Corsano™ multi-parameter wearable should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.

Corsano™ 多参数可穿戴设备不应作为诊断或治疗的唯一依据，仅用作患者评估的辅助工具。

† Based on studies done on technologies using the same or some of the same features as the Corsano™ multi-parameter wearable and may not be indicative of its performance.

† 基于对使用与 Corsano™ 多参数可穿戴设备相同或部分相同功能的技术进行的研究，可能无法反映其性能。

‡ The Corsano™ multi-parameter wearable device is not intended for use on acutely ill cardiac patients with potential to develop life-threatening arrhythmias, or SpO2 monitoring in conditions of high motion or low perfusion.

‡ Corsano™多参数可穿戴设备不适用于有可能发展为危及生命的心律失常的急性心脏病人，也不适用于在高运动或低灌注条件下进行SpO2监测。

References

参考文献

Corsano™ multi-parameter wearable monitor IFU.

Corsano™ 多参数可穿戴监测仪使用说明书。

Eddahchouri Y, Peelen RV, Koeneman M, Touw HR, van Goor H, Bredie SJ. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. British Journal of Anaesthesia. 2022 May 1;128(5):857-63.

Eddahchouri Y, Peelen RV, Koeneman M, Touw HR, van Goor H, Bredie SJ。连续无线生命体征监测对非计划ICU入院和快速反应小组呼叫的影响：一项前后对照研究。《英国麻醉学杂志》。2022年5月1日；第128卷第5期：857-63页。

Becking-Verhaar FL, Verweij RP, de Vries M, Vermeulen H, van Goor H, Huisman-de Waal GJ. Continuous vital signs monitoring with a wireless device on a general ward: a survey to explore nurses’ experiences in a post-implementation period. International Journal of Environmental Research and Public Health.

贝克林-费拉尔 FL，费尔韦伊 RP，德弗里斯 M，费尔梅伦 H，范戈尔 H，惠斯曼-德瓦尔 GJ。在普通病房使用无线设备进行持续生命体征监测：实施后阶段护士体验的调查。《国际环境研究与公共卫生杂志》。

2023 May 11;20(10):5794..

2023年5月11日；20（10）：5794。

Rowland BA, Motamedi V, Michard F, Saha AK, Khanna AK. Impact of continuous and wireless monitoring of vital signs on clinical outcomes: a propensity-matched observational study of surgical ward patients. British Journal of Anaesthesia. 2024 Mar 1;132(3):519-27.

Rowland BA, Motamedi V, Michard F, Saha AK, Khanna AK。连续无线监测生命体征对临床结果的影响：一项针对外科病房患者的倾向匹配观察性研究。《英国麻醉学杂志》。2024年3月1日；132(3):519-27。

Sun L, Joshi M, Khan SN, Ashrafian H, Darzi A. Clinical impact of multi-parameter continuous non-invasive monitoring in hospital wards: a systematic review and meta- analysis. Journal of the Royal Society of Medicine. 2020 Jun;113(6):217-24.

孙L，乔希M，汗SN，阿什拉菲安H，达齐A。多参数连续无创监测在医院病房的临床影响：一项系统评价和荟萃分析。《皇家医学会杂志》。2020年6月；113（6）：217-24。

Areia C, King E, Ede J, Young L, Tarassenko L, Watkinson P, Vollam S. Experiences of current vital signs monitoring practices and views of wearable monitoring: A qualitative study in patients and nurses. Journal of advanced nursing. 2022 Mar;78(3):810-22.

Areia C, King E, Ede J, Young L, Tarassenko L, Watkinson P, Vollam S. 当前生命体征监测实践的体验及对可穿戴监测的看法：患者与护士的定性研究。《高级护理杂志》。2022年3月；78(3):810-22。

Verrillo SC, Cvach M, Hudson KW, Winters BD. Using Continuous Vital Sign Monitoring to Detect Early Deterioration in Adult Postoperative Inpatients. J Nurs Care Qual. 2019 Apr/Jun;34(2):107-113. doi: 10.1097/NCQ.0000000000000350. PMID: 30095509.

维里洛 SC，卡瓦奇 M，哈德森 KW，温特斯 BD。使用连续生命体征监测检测成人术后住院患者早期恶化。《护理质量杂志》。2019年4月/6月；34(2):107-113。doi: 10.1097/NCQ.0000000000000350。PMID: 30095509。

Weller GB, Mault J, Ventura ME, Adams J, Campbell FJ, Tremper KK. A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients. J Clin Med. 2024 Aug 13;13(16):4747. doi: 10.3390/jcm13164747. PMID: 39200889; PMCID: PMC11355593..

Weller GB, Mault J, Ventura ME, Adams J, Campbell FJ, Tremper KK。通过医疗级可穿戴设备对住院楼层患者进行连续无线生命体征监测的回顾性观察研究。《临床医学杂志》。2024年8月13日；13(16):4747。doi: 10.3390/jcm13164747。PMID: 39200889；PMCID: PMC11355593。

Contacts

联系人

Maria Trenzado Communications

玛丽亚·特伦扎多通信公司

+34-653-30-4720

+34-653-30-4720

Ryan Weispfenning Investor Relations

瑞安·魏斯芬宁 投资者关系

+1-763-505-4626

+1-763-505-4626